CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-blinded, Placebo-controlled Study of Rituximab in Patients with Psychosis And/or Obsessive Compulsive Disorder, with an Indication of Immune System Involvement

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04323566
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:07.301023+00:00
Published At: 2024-11-19T00:00:00+00:00
Record Updated At: 2024-11-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Obsessive-Compulsive Disorder", "Obsessive-Compulsive Behavior", "Schizophrenia", "Delusional Disorder", "Brief Psychotic Disorder", "Schizo Affective Disorder", "Other Psychoses", "Unspecified Psychosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-11-19"
protocolSection.identificationModule.nctId: "NCT04323566"
protocolSection.identificationModule.officialTitle: "A Randomized, Double-blinded, Placebo-controlled Study of Rituximab in Patients with Psychosis And/or Obsessive Compulsive Disorder, with an Indication of Immune System Involvement"
protocolSection.statusModule.overallStatus: "ENROLLING_BY_INVITATION"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.